Tightness of Chest, discomfort of breathing duringmidnight or Early morning, stop the breathing (suddenly), Breathing stress (duringemotional conditions), lack of breath, Anxiety,Recurrent respiratory infections in environment changes, Cough, Cold extremity,people not able to speak full sentence,take precautions it may be a sign of asthma attack.
Bronchial asthma is a disease of the upper
respiratory tract, our upper respiratory tract produce symptoms lsuch as shortness of
breath in midnight wheez and cough periodically with change the environment.
It is termed as a reversible condition of upper
respiratory tract of bronchus associated
with inflammation of airway, reversible changes in smooth muscle of bronchioles
with hyper-responsiveness.
Due to inflammation of the mucosa, spasm of bronchial
smooth muscle and over production of mucus reduce the diameter of upper
respiratory tract with occlusion and narrowing.
- Intrinsic
- Extrinsic
- Mixed
|
|
Features
|
Intrinsic
|
Extrinsic
|
Age
|
In
adult
|
In
child hood
|
Personal/Family
history
|
Absent
|
Commonly
present
|
Preceding
allergic illness
|
Absent
|
Present
|
Allergens
|
None
|
present
|
Drug
hypersensitivity
|
Present
(usually aspirin)
|
None
|
Serum
IgG levels
|
Normal
|
Elevated
|
Associated
chronic bronchitis, nasal Polyps
|
Present
|
Absent
|
Emphysema
|
Common
|
Unusual
|
It is included in chronic obstructive disease because
it produce COPD like symptoms.
According to National Center for Health Statics and Center
for Disease Control and Prevention it
is in United States has increased from 7.3% to 8.4% in 2010. About 1 in 11
children and 1 in 12 adults suffered from asthmatic conditions. It is
approximate 27.7 million people in United States suffered from this condition. According to WHO about 235 million people worldwide
suffering from asthma.
Frequency
|
sever controlled
|
Sever
uncontrolled
|
More
then once a day
|
18%
|
55%
|
once
a day
|
8%
|
15%
|
More
than 2 times per week, but not daily
|
27%
|
22%
|
2
or less times per week, but not daily
|
36%
|
8%
|
Rarely
|
11%
|
0%
|
Environmental Factor
•
Allergies from –
fumes, cold air, dust and other product.
•
Upper
respiratory tract infection with Bacteria, virus and fungal infection).
•
Smoking and
tobacco chewing.
•
Occupational
pollutants-eg. Sugar cane factory workers, formers.
•
Drugs (NASAID,
Aspirin and B-Blockers).
•
Asthma attack
during exercise (exercise induce asthma).
•
Asthma attack
during Anxiety or in Emotional condition.
•
Idiopathic or
related with autoimmune condition.
Host Factor
•
Genetically
inherited asthma attack
•
Asthma attack produce during obesity
•
Sex
or Gender
It is 2 times more common
in boys before 14 years and in adults it is more common in women.
Following
changes occurs in upper respiratory tract in asthma
- Respiratory tract is hyper responsive may produces inflammation
and increase production of mucus in excess amount within the airway. It may be normal
or degenerated.
- Inflammation and hyper responsive of airway and
increase amount of mucus production produced by some infections or allergens within
the respiratory tract.
- Increase thickening of bronchial basement membrane
because changes of epithelium and form twist strips due to collection of
eosinophils in sputum.
- After collection of lymphocytes, eosinophils and
plasma cells it may produce hypertrophy of submucosal glands and submucosal
edema.
It is an obstructive pathology may produce following
sing and symptoms
- Shortness
of breath in midnight
- Feeling of anxiety
- Cyanosis
may be present because of hypoxia due to lack of oxygen
- Cold
extremity
- Usually
wheez Crepitus/Crackles type
of abnormal sounds are present
- Cough
is more common sign in asthma patients
- Patient
not able to speak full sentence
- Pulsus
paradox changes in breathing pattern in severe cases
- Barrel
shape chest deformity because increase anterior posterior diameter
- Present tripod sign in sever cases
- Hyper
resonant percussion note are present
- Decrease tactile vocal fremitus with diminish breath sound
- I: E ratio it will be changed >1:3
Global initiative for asthma (GINA) provides general guideline to help in the clinical
diagnosis of asthma, which are based on patient’s symptoms and medical history.
These are includes wheezing and history of following-
- Recurrent tightness of chest in patients
- Recurrent difficult of breathing in patients
- Recurrent cough in patients
- Recurrent wheez type of abnormal sound
Following
tests are used to diagnose the asthma attack
Pulmonary Function Test
This test measure the variability of airflow
limitation, severity, reversibility
Following findings suggest it may be asthma
- FEV1 =increase FEV1 of 12% (<200ml) after
bronchodilator use suggest asthma attack
- FEV1/FVC ratio = < 0.75 to 0.85
- PEFR =60 L/m > =10-20%
Moderate To Severe Asthmatic Episode
(Obstructive Lung Pathology)
Forced Expiratory Volume and Flow Rate Findings
FVC FEV1 FEV1/FV Ratio FEF25%-75%
↓ ↓ ↓ ↓
FEF50% FEF200-1200 PEFR MVV
↓
↓ ↓ ↓
Lung Volume and lung Capacity Findings
IRV ERV VT RV
↓or Normal ↓ or Normal ↑or Normal ↑
VC IC FRC TLC RV/TLC Ratio
↓ ↓or Normal ↑
↑ or Normal ↑or Normal
Note-FVC-forced vital capacity, FEV1-force expiratory
volume in one second, FEV1/FVC ratio-Ratio of FVC and FEV1, FEF-force
expiratory flow 25%-75%, PEFR-peak expiratory flow rate, MVV-maximum voluntary
ventilation, VT-Tidal volume, IRV-inspiratory reserve volume, ERV- expiratory
reserve volume, Residual volume,VC-vital capacity, IC-inspiratory capacity,
FRC-functional residual capacity, TLC-total lung capacity.
Mild to Moderate Asthmatic Episode
Acute Alveolar Hyperventilation with Hypoxemia
(Acute Respiratory
Alkalosis)
pH PaCO2 HCO3 − PaO2 SaO2 or SpO2
↑ ↓ ↓
Normal
↓ ↓
Severe Asthmatic Episode (Status Asthmatics)
Acute Ventilatory Failure with Hypoxemia
(Acute Respiratory Acidosis)
pH PaCO2 HCO3 − PaO2 SaO2
or SpO2
↓ ↑
↑
↓ ↓
Other
diagnostic test
Measure PEFR with peak flow meter
(during asthmatic episode)
- Shape chest-increase anterior/posterior
diameter
- Translucent lung field (dark)
- Depressed or flattened diaphragm.
- COPD
- Tropical eosinophilia
- Obstruction of upper respiratory tract
- Allergic lung disease other than asthma
- Medical
- Surgical
- Physiotherapy
Medical
management-
National asthma education and prevention plan (NAEPP)
and
(GINA) Global initiative for asthma provide evidence based guideline for asthma management.
- Attain and maintain control of clinical
manifestations associated with asthma.
- Maintain normal activity level, including
exercise'
- Normalize
or maintain respiratory functions as possible
- Prevent asthma exarvation
- Avoid adverse effects from asthma
medication
- Prevent asthma mortality
Component 1: Develop
patients/doctor partnership
Component 2: Reduce and identify
exposure to risk factors
Component 3: Assess,
treat and monitor asthma
Component 4: Manage
asthma exacerbation
Component 5: Special
considerations eg. Pregnancy, obesity, surgery and others.
- Mechanical ventilation
noninvasive or invasive (if required)
- Oxygen therapy protocol
(if needed)
- Nebulization therapy protocal
- Following Drugs are used
to maintain patients
- LABAs (long acting Beta2
agents)
- Inhaled corticosteroids
- Combination of Beta2
agents and corticosteroids
- Leukotriene inhibitors
- Xanthine derivatives
- SABAs (short acting Beta2
agents
- Ultra-short acting
bronchodilators
Bronchial thermosplasty
Goals for physiotherapy management-
- Prevent intubation
- Prevent mechanical ventilation invasive or noninvasive
both
- Reduce dyspnea
- Facilitation mucociliary transport
- Optimize secretion transport
- Optimize alveolar ventilation
- Decrease work of breathing
- Normalize respiratory rate
- Decrease work of heart